
Philipp Koehler
@koehlerph
MD, FIDSA, FECMM. Hematology &Oncology, Rheumatology, Intensive Care, Infectious Diseases. Tweets are my own & do not represent endorsements or medical advice
ID: 1152328496896720896
https://publons.com/researcher/1593262/philipp-koehler/publications/ 19-07-2019 21:24:57
192 Tweet
375 Followers
202 Following

New in The Lancet Infectious Diseases> Guideline adherence and survival of patients with #candidaemia in Europe: results from the ECMM #Candida III multinational European observational cohort study thelancet.com/journals/lanin…




📢 Call for RCT investigating trimetoprim-sulfamethoxazole + echinocandin for #Pneumocystis pneumonia in non-HIV patients Oliver Cornely Jürgen Prattes Philipp Koehler sciencedirect.com/science/articl…

🔥Which 🍄 trial do we need? Combination treatment - TMP-SMX plus an echinocandin for Pneumocystis jirovecii pneumonia in non-HIV infected patients - find our thoughts and ideas Clinical Microbiology and Infection 👉authors.elsevier.com/a/1hAxN,RGPgSB… by Jürgen Prattes, Oliver Cornely & colleagues from Uniklinik Köln, CECAD Cologne

#Pre_print 📢3rd doses of #Pfizer or #Moderna #COVID19 increase ↗️antibodies 14 days post-#vaccination in #elderly Full details of this VACCELERATE Consortium 🇪🇺🇺🇦 #RCT👇👇 papers.ssrn.com/sol3/Delivery.… Jannik Stemler Philipp Koehler Oliver Cornely Uniklinik Köln HaDEA CECAD Cologne DZIF (inaktiv) DZIF Bonn-Köln


📢finally out in Oxford Academic JAC🥳 Antifungal prophylaxis guideline by ID Working Group DGHO e. V. tinyurl.com/mr3948zf ✅evidence-based ✅overview tables ✅study summaries in suppl Great team effort! Oliver Cornely Rosanne Sprute Sibylle Mellinghoff Philipp Koehler Martin Hoenigl🇺🇦🇦🇹

🆕️⚡️🔥 #JAC 🌟s Jannik Stemler Oliver Cornely Rosanne Sprute Sibylle Mellinghoff Philipp Koehler Martin Hoenigl🇺🇦🇦🇹 Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies 2022 update German Society for Haematology&Medical Oncology academic.oup.com/jac/article/do…


💊 Phase 1b safety and pharmacokinetics of intravenous and oral #formanogepix in patients with acute myeloid leukaemia and neutropenia Oliver Cornely Philipp Koehler academic.oup.com/jac/advance-ar…

🔥🔥 Public consultation #Global #Candida #Guideline NOW ➡️clinicalsurveys.net/uc/GL_Candida 🙏🙏🙏ECMM ISHAM Neil Gow Martin Hoenigl🇺🇦🇦🇹 Matteo Bassetti Oliver Kurzai @DrLuisO Rosanne Sprute Jon Salmanton-García 🔎🍄🩸💉🦠 Birgit Willinger Please RT📢need your input📢

Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM. This is a great achievement which confirms many years of hard work. Many thanks to all the contributors. Intensive Care Medicine


Honored, grateful and humbled - I have been ID’ed as a Fellow of IDSA. Thanks to all colleagues, collaborators and mentors, especially Oliver Cornely and to the ID Team Uniklinik Köln Universität zu Köln #WeAreID #ThinkFungus


🔥📰 Attributable mortality of candidemia – Results from ECMM Candida III multinational European Cohort Study Attributable mortality overall 18.1%, driven by non-albicans Candida. 🙏🏻 Jon Salmanton-García 🔎🍄🩸💉🦠 Philipp Koehler Oliver Cornely Martin Hoenigl🇺🇦🇦🇹 & others journalofinfection.com/article/S0163-…

My interview for austrian national television on attributable mortality of candidemia and the ECMMCandida III study. Great study Jon Salmanton-García 🔎🍄🩸💉🦠 Philipp Koehler Oliver Cornely and others! ECMM Med Uni Graz on.orf.at/video/14235715…

Which #trial do we need? Shorter #antifungal treatment for #candidemia – challenging the 14-day dogma. Clinical Microbiology and Infection: sciencedirect.com/science/articl… #fungalinfections #IFI Nico Bekaan Tim Friede Rosanne Sprute Philipp Koehler Jon Salmanton-García 🔎🍄🩸💉🦠 Jannik Stemler

👉Participate in ECMM Candida IV 🌎wide study on candidemia caused by non-albicans Candida spp. Requirement: clinical data & isolate (not req for C.auris) Reward: Reimbursement & Authorship Observation period: 04/2024 - 09/2025 Interested? 📧 [email protected]


👉Participate in ECMM ECMM Candida IV Study 🌍wide study on candidemia caused by non-albicans Candida Requirement: clinical data & isolate (not req for C.auris) Observation period: 04/2024 - 09/2025 Interested? DM Stella Wolfgruber or Sarah Sedik
